FTC seeks more information on Novo Nordisk parent-Catalent deal

[cafead]

via The U.S. FTC has sought more information on Novo Nordisk (NOVOb.CO) parent's $16.5 billion bid for contract drug manufacturer Catalent (CTLT.N), weeks after an application to the regulator was refiled for approval of the deal.

article source